Jae-Kyo Kim
Vermogen: 1 M $ op 31-05-2026
Vermogen: 1 M $ op 31-05-2026
Jae-Kyo Kim currently works at Hanmi Science Co., Ltd., as Vice Chairman & Chief Executive Officer from 2025.
Mr. Kim also formerly worked at Yuhan Corp., as Director & Head-Global Strategy.
Mr. Kim received his undergraduate degree from Kyungpook National University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
Immuneoncia Therapeutics, Inc.
Immuneoncia Therapeutics, Inc. BiotechnologyHealth Technology Provides drug development and antibody engineering services for oncology patients 0,3% | 30-04-2025 | 269.370 ( 0,3% ) | 1 M $ | 31-05-2026 |
| 24-06-2026 | 9.494 ( 0,01% ) | 200 023 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| HANMI SCIENCE CO., LTD. | Algemeen Directeur | 26-03-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| YUHAN CORPORATION | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Yuhan Corp.
Yuhan Corp. Pharmaceuticals: MajorHealth Technology Engages in the manufacture and marketing of pharmaceutical products | Health Technology |
Kyungpook National University
Kyungpook National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hanmi Science Co., Ltd.
Hanmi Science Co., Ltd. Medical DistributorsDistribution Services Operates as a holding company whose subsidiaries engages in pharmaceutical wholesale & manufacturing and medical device production activities | Distribution Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau